From the research index
The paper comes from the research index. It wasn’t submitted here.
VOLT CE Mark Study
Ruffner
Clinical trial record
Registered before results. Outcomes may change.
VOLT CE Mark Study
Ruffner · NCT06106594
- Sponsor
- Abbott Medical Devices
- Started
- 24 Oct 2023
- Trial ID
- NCT06106594
Abstract
This clinical investigation is intended to demonstrate safety and effectiveness of the Volt™ Pulsed Field Ablation (PFA) Catheter Sensor Enabled™, the Volt™ PFA Generator, Agilis™ NxT Steerable Introducer Dual-Reach™, and EnSite™ X EP System EnSite™ Pulsed Field Ablation Module (for simplicity of reference this device collection will hereafter be referred to as the Volt™ PFA system) for the treatment of symptomatic, recurrent, drug-refractory paroxysmal and persistent atrial fibrillation.